VENTRIA BIOSCIENCE — Department of Health and Human Services SBIR Phase I: DESCRIPTION (provided by applicant): Epithelial cell lines such as Vero and MDCK are used
VENTRIA BIOSCIENCE — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $158,820
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Solicitation
- PA10-050
- NAICS
- —
- Place of performance
- CO
- Period
- —
Description
DESCRIPTION (provided by applicant): Epithelial cell lines such as Vero and MDCK are used in the production of viral based vaccines. The use of cell based vaccines is growing. The majority of the vaccines in use today are produced in medium supplemented with serum. The use of animal-derived products in vaccine culture media presents a risk for the transmission of infectious disease on a wide scale. Current commercially available serum-free vaccine media, are not defined, inconsistent, and do not offer the same performance as media supplemented with serum. We propose to produce a superior performance, defined, animal-free, cell culture medium for vaccine production. Our project addresses the call by agencies for a safe alternative to animal-derived componentsin vaccine production. PUBLIC HEALTH RELEVANCE: Epithelial cell lines such as Vero and MDCK are used in the generation of viral based vaccines and their use is expanding. Current commercially available animal-free vaccine production media are not defined and do not offer the same performance as media supplemented with serum. We propose the industry's first defined, high performance animal-free, cell culture medium to increase safety and the production of vaccines.